Pulmonary Hypertension (PH)

DBCOND0051788Cardiovascular DiseasesRespiratory Tract Diseases

Pulmonary Hypertension (PH) is the indication for 5 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Pulmonary Hypertension
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT020943ICD-10I27.0SNOMED CT155328008MedDRA10037401UMLSC0020542

What you can answer from here — as of October 22, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
440Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
3Boxed warningsLabel boxed warnings that name this condition
Sign in
36Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Pulmonary Hypertension (PH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In